Advancements in Thyroid Cancer Management

A special issue of Current Oncology (ISSN 1718-7729). This special issue belongs to the section "Head and Neck Oncology".

Deadline for manuscript submissions: 31 May 2025 | Viewed by 79

Special Issue Editor


E-Mail Website
Guest Editor
Department of Surgical, Medical, Molecular Pathology and Critical Area, Unit of Endocrine Surgery, Pisa University Hospital, 56124 Pisa, Italy
Interests: thyroid cancer; active surveillance; targeted therapy; lymph node dissection; surgical treatment
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Thyroid cancer has witnessed a notable increase in incidence over recent decades, prompting a continuous evolution in diagnostic modalities and therapeutic strategies. While surgical interventions have long been the cornerstone of thyroid cancer management, the landscape of treatment has expanded significantly to encompass medical therapies, radioiodine ablation, and targeted therapies. This Special Issue aims to provide a comprehensive overview of the latest advancements across the spectrum of thyroid cancer treatment. By bringing together the expertise of leading researchers and clinicians in the field, this Special Issue will serve as a valuable resource for anyone involved in the care of patients with thyroid cancer.

We invite original research articles, review articles, and meta-analyses that address the following key areas:

  • Surgical advancements: The evolution of surgical techniques, driven by technological advancements and a deeper understanding of the disease, has significantly improved patient outcomes. Contributions exploring minimally invasive and remote-access surgery, nodal management, and the management of advanced disease are encouraged.
  • Medical therapies: the role of medical therapies, including tyrosine kinase inhibitors and other targeted agents, is of great interest in the management of thyroid cancer, both as adjuvant and first-line treatments.
  • Emerging technologies: The field of thyroid cancer treatment is continually evolving. Contributions exploring emerging technologies, such as US-guided ablation, and their potential applications in thyroid cancer are welcome.
  • Quality of life and patient-reported outcomes: The impact of treatment on patients' quality of life is a critical consideration. Studies investigating the long-term functional outcomes, cosmetic results, and patient satisfaction following thyroid cancer treatment are encouraged. Moreover, we reserve special attention to active surveillance.

Dr. Leonardo Rossi
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Current Oncology is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • thyroid cancer
  • active surveillance
  • targeted therapy
  • lymph node dissection
  • thyroid nodule ablation
  • remote-access thyroidectomy
  • minimally invasive thyroidectomy
  • medullary thyroid carcinoma
  • anaplastic thyroid carcinoma

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop